The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study

BACKGROUND: The durability of vaccine-induced humoral immunity against SARS-CoV-2 in patients with immune-mediated inflammatory diseases (IMIDs) on immunosuppressive therapy is not known. The aim of this study was to compare the persistence of anti-Spike antibodies following two-dose SARS-CoV-2 vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Ingrid Egeland, Jyssum, Ingrid, Tveter, Anne Therese, Sexton, Joseph, Tran, Trung T., Mjaaland, Siri, Kro, Grete Birkeland, Kvien, Tore K., Warren, David John, Jahnsen, Jørgen, Munthe, Ludvig A., Haavardsholm, Espen A., Vaage, John Torgils, Grødeland, Gunnveig, Lund-Johansen, Fridtjof, Jørgensen, Kristin Kaasen, Syversen, Silje Watterdal, Goll, Guro Løvik, Provan, Sella Aarrestad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534475/
https://www.ncbi.nlm.nih.gov/pubmed/36199139
http://dx.doi.org/10.1186/s12916-022-02587-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534475/
https://www.ncbi.nlm.nih.gov/pubmed/36199139
http://dx.doi.org/10.1186/s12916-022-02587-8

Ejemplares similares